{
    "2020-01-16": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Afraid of sky-high stock valuations? These ‘Dividend Aristocrats’ have yields over 3%",
                "features": {
                    "keywords": [
                        "Afraid",
                        "sky-high",
                        "stock valuations",
                        "Dividend Aristocrats",
                        "yields"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividends"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "T. Rowe Price Equity Income Fund Invests in Utility Company CenterPoint Energy",
                "features": {
                    "keywords": [
                        "T. Rowe Price",
                        "Equity Income Fund",
                        "Utility Company",
                        "CenterPoint Energy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "utilities"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Form 8.3 - ABBVIE INC - AMENDMENT",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "ABBVIE INC",
                        "AMENDMENT"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Form 8.3 - Abbvie Plc",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "Abbvie Plc"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}